Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

WebMD Increases Stock Repurchase Program

WebMD Health Corp.
Posted on: 19 Sep 16

PR Newswire

NEW YORK, Sept. 19, 2016

NEW YORK, Sept. 19, 2016 /PRNewswire/ -- WebMD Health Corp. (NASDAQ WBMD) today announced an increase in the amount available under WebMD's existing stock repurchase program to $50 million, an increase of approximately $35 million over the amount remaining from prior authorizations.  Under the repurchase program, WebMD may repurchase shares of its Common Stock from time to time in the open market, through block trades or in private transactions, depending on market conditions and other factors.

About WebMD

WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications.

The WebMD Health Network includes WebMD.com, Medscape.com, MedicineNet.com, eMedicineHealth.com, RxList.com, Medscape Education (Medscape.org) and other WebMD owned sites and apps.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements.  These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements, including risks and uncertainties regarding: changes in financial markets; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology industries; and changes in other facts and circumstances affecting repurchases of our common stock.  Further information about these matters can be found in our Securities and Exchange Commission filings.  Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

Logo - http://photos.prnewswire.com/prnh/20150811/257757LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/webmd-increases-stock-repurchase-program-300329992.html

SOURCE WebMD Health Corp.

PR Newswire
www.prnewswire.com

Last updated on: 19/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.